BANK OF AMERICA CORP /DE/
BankPosition in AVIR — Atea Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$380,043
-$188,300 QoQ
Shares Held
81,730
-22.6% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. AVIR ranks #257 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $380,043 | 81,730 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $568,343 | 105,640 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $484,783 | 135,794 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $909,565 | 313,644 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $395,059 | 109,739 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $181,375 | 60,661 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $246,026 | 73,441 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $199,455 | 59,539 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $229,968 | 69,477 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $270,946 | 67,066 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $743,358 | 243,724 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $289,296 | 96,432 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $383,386 | 102,510 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $457,350 | 136,523 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $838,603 | 174,346 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $731,044 | 128,479 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $321,295 | 45,253 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $270,843 | 37,513 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,111,936 | 124,378 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,249,187 | 35,630 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,394,030 | 64,899 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,501,142 | 24,310 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $592,941 | 14,192 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||